文献速递妇科生殖医学

宫颈上皮内瘤变与生育力:一项前瞻性队列研究

Cervical intraepithelial neoplasia and fecundability: a prospective cohort study.
PubMed 文献 · Hum Reprod · 2024-01-01

该前瞻性队列纳入9586名尝试受孕女性,基于丹麦国家病理登记处CIN诊断分析生育力。总体未发现CIN与生育力之间存在有意义的关联,但诊断后2年内中度或重度CIN可能与生育力轻微降低相关。

要点

  • 与无病变相比,CIN1、CIN2+未手术及CIN2+手术的调整生育力比均接近1,无显著关联。
  • 近期(<2年)诊断CIN2+未手术者调整FR为0.89(95%CI 0.62-1.26),CIN2+手术者为0.91(0.75-1.10)。
  • 原文指出CIN诊断可能自发消退或进展,存在错分可能,尤其正常细胞或CIN1女性。

核心结论

  • 总体未观察到CIN与生育力之间有意义的关联,无论手术状态如何。
  • 近期诊断中度或重度CIN可能在诊断后2年内与生育力轻微降低相关。

研究设计与样本

  • 前瞻性队列研究,纳入9586名尝试受孕女性,入组时间为2007年6月1日至2020年2月3日。
  • 女性完成基线问卷及每两个月一次随访问卷,最长12个月或直至妊娠。
  • 宫颈细胞学和活检数据来自丹麦国家病理登记处(DNPR),该登记处保存丹麦所有宫颈标本检查记录。
  • 按最严重CIN诊断分类:无病变、其他宫颈改变、轻度CIN(CIN1)、中度/重度CIN(CIN2+)伴或不伴手术。
  • 采用比例概率回归模型计算生育力比(FR)及95%置信区间(CI),并调整年龄、伴侣年龄、体重指数、吸烟状态、性交时机、产次、教育、性伴侣数及家庭收入。

主要发现

  • 与无病变相比,其他宫颈病变调整FR为0.97(95%CI 0.91-1.04)。
  • 与无病变相比,CIN1调整FR为1.04(95%CI 0.96-1.13)。
  • 与无病变相比,CIN2+未手术调整FR为1.00(95%CI 0.82-1.22)。
  • 与无病变相比,CIN2+手术调整FR为0.99(95%CI 0.89-1.10)。
  • 近期(<2年)诊断与无病变组相比:其他宫颈病变FR 0.98(95%CI 0.86-1.11);CIN1 FR 1.13(0.99-1.29);CIN2+未手术FR 0.89(0.62-1.26);CIN2+手术FR 0.91(0.75-1.10)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 分析中调整了多个女性相关协变量,但男性伴侣信息很少,可能导致未测量混杂,因为生育力是夫妇层面的生育指标。
  • CIN诊断可能不恒定,可自发消退或进展,因此可能对部分女性发生错分,尤其是分类为正常细胞或CIN1的女性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is cervical intraepithelial neoplasia (CIN) associated with reduced fecundability, defined as the probability of conceiving per menstrual cycle? SUMMARY ANSWER: Overall, we observed no meaningful association between CIN and fecundability, regardless of surgical status, although a recent diagnosis of moderate or severe CIN might be associated with slightly reduced fecundability for 2 years after diagnosis. WHAT IS KNOWN ALREADY: About 15% of couples experience infertility. Few studies have examined the influence of CIN on fertility, and the results have been inconsistent. No study has investigated the association between fecundability and pathologist-reported CIN diagnoses, particularly with respect to the recency of the specific CIN diagnoses. STUDY DESIGN, SIZE, DURATION: This prospective cohort study included 9586 women trying to conceive. The women were enrolled from 1 June 2007 to 3 February 2020. PARTICIPANTS/MATERIALS, SETTING, METHODS: Women were invited to complete a baseline questionnaire and bimonthly follow-up questionnaires for up to 12 months or until pregnancy occurred. Data on cervical cytologies and biopsies were retrieved from The National Pathology Registry (DNPR), which holds records of all cervical specimens examined in Denmark. Women were categorized based on their most severe diagnosis of CIN: no lesion, other cervical changes, mild CIN (CIN1), or moderate/severe CIN (CIN2+) with or without surgery. To investigate the association between CIN and fecundability, we computed fecundability ratios (FR) and 95% confidence intervals (CI) using a proportional probabilities regression model. We adjusted for age at study entry, partner age, body mass index, smoking status, timing of intercourse, parity, education, number of sexual partners, and household income. MAIN RESULTS AND THE ROLE OF CHANCE: Compared with no lesion, the adjusted FRs (95% CI) for the association between CIN and fecundability were: other cervical lesions, 0.97 (0.91-1.04); CIN1, 1.04 (0.96-1.13); CIN2+ no surgery, 1.00 (0.82-1.22); and CIN2+ with surgery 0.99 (0.89-1.10). The FRs (95% CI) for a recent diagnosis (<2 years) of CIN were 0.98 (0.86-1.11) for other cervical lesions; 1.13 (0.99-1.29) for CIN1; 0.89 (0.62-1.26) for CIN2+ no surgery and 0.91 (0.75-1.10) for CIN2+ with surgery compared with the no lesion group. LIMITATIONS, REASONS FOR CAUTION: In the analyses, we adjusted for several covariates related to the women. However, we had little information on the male partners which could lead to unmeasured confounding as fecundability is a couple-based measure of fertility. Furthermore, a CIN diagnosis may not be constant as it may regress or progress spontaneously; therefore, it is possible that we have misclassified some women, especially women categorized as having normal cells or CIN1. WIDER IMPLICATIONS OF THE FINDINGS: Our results contribute important knowledge to women who are concerned about their future fertility after receiving a CIN diagnosis. STUDY FUNDING/COMPETING INTEREST(S): This study was funded by The Danish Cancer Society (R167-A11036-17-S2). The overall cohorts were funded by the National Institute of Child Health and Human Development (R01-HD086742 and R03-HD094117). The authors report no competing interests. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Kristensen ML, Waldstrøm M, Laursen ASD, et al. Cervical intraepithelial neoplasia and fecundability: a prospective cohort study. Hum Reprod. 2024. PMID: 38906838. doi:10.1093/humrep/deae139

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。